Trexquant Investment’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-223,121
Closed -$2.03M 1870
2025
Q2
$2.03M Sell
223,121
-410,504
-65% -$3.02M 0.02% 879
2025
Q1
$5.04M Buy
633,625
+488,963
+338% +$3.58M 0.06% 500
2024
Q4
$786K Sell
144,662
-30,999
-18% -$190K 0.01% 1175
2024
Q3
$1.27M Sell
175,661
-139,582
-44% -$1.28M 0.02% 968
2024
Q2
$3.42M Buy
315,243
+287,385
+1,032% +$3.68M 0.05% 534
2024
Q1
$522K Sell
27,858
-75,239
-73% -$1.74M 0.01% 1130
2023
Q4
$2.23M Buy
+103,097
New +$2.04M 0.05% 513
2023
Q1
Sell
-20,249
Closed -$772K 1726
2022
Q4
$772K Sell
20,249
-1,345
-6% -$51.4K 0.02% 750
2022
Q3
$846K Buy
+21,594
New +$835K 0.03% 591
2022
Q1
Sell
-6,599
Closed -$281K 1672
2021
Q4
$281K Buy
+6,599
New +$276K 0.02% 959
2020
Q2
Sell
-24,897
Closed -$715K 1432
2020
Q1
$715K Buy
+24,897
New +$1.44M 0.05% 526
2019
Q1
Sell
-2,164
Closed -$207K 1278
2018
Q4
$207K Sell
2,164
-1,359
-39% -$156K 0.01% 906
2018
Q3
$498K Sell
3,523
-16,682
-83% -$2.57M 0.04% 539
2018
Q2
$3.16M Buy
+20,205
New +$3.17M 0.22% 155
2017
Q2
Sell
-6,108
Closed -$434K 1121
2017
Q1
$434K Sell
6,108
-3,792
-38% -$222K 0.06% 595
2016
Q4
$505K Sell
9,900
-7,900
-44% -$372K 0.08% 429
2016
Q3
$820K Buy
+17,800
New +$725K 0.18% 166
2015
Q2
Sell
-25,815
Closed -$1.3M 1207
2015
Q1
$1.3M Buy
+25,815
New +$1.11M 0.13% 261

Other funds holding SAGE